Tower Research Capital LLC (Trc) Fulcrum Therapeutics, Inc. Transaction History

Tower Research Capital LLC (Trc)

  • $3.68 Billion
  • Q3 2024

A detailed history of Tower Research Capital LLC (Trc) transactions in Fulcrum Therapeutics, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 28,120 shares of FULC stock, worth $127,946. This represents 0.0% of its overall portfolio holdings.

Number of Shares
28,120
Previous 16,324 72.26%
Holding current value
$127,946
Previous $101,000 0.99%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$3.18 - $9.74 $37,511 - $114,893
11,796 Added 72.26%
28,120 $100,000
Q2 2024

Aug 13, 2024
BUY
$5.98 - $9.31 $38,708 - $60,263
6,473 Added 65.71%
16,324 $101,000
Q1 2024

May 15, 2024
BUY
$6.7 - $12.0 $41,493 - $74,316
6,193 Added 169.3%
9,851 $92,000
Q4 2023

Feb 13, 2024
SELL
$3.18 - $6.86 $5,053 - $10,900
-1,589 Reduced 30.28%
3,658 $24,000
Q3 2023

Nov 14, 2023
SELL
$3.25 - $6.08 $18,762 - $35,099
-5,773 Reduced 52.39%
5,247 $23,000
Q2 2023

Aug 14, 2023
BUY
$2.26 - $3.8 $11,525 - $19,380
5,100 Added 86.15%
11,020 $36,000
Q1 2023

May 09, 2023
BUY
$2.83 - $13.99 $11,591 - $57,303
4,096 Added 224.56%
5,920 $17,000
Q4 2022

Feb 10, 2023
SELL
$5.01 - $8.35 $1,447 - $2,413
-289 Reduced 13.68%
1,824 $13,000
Q3 2022

Nov 10, 2022
SELL
$4.92 - $9.1 $18,646 - $34,489
-3,790 Reduced 64.2%
2,113 $17,000
Q2 2022

Aug 15, 2022
BUY
$4.2 - $24.0 $22,003 - $125,736
5,239 Added 789.01%
5,903 $28,000
Q1 2022

May 12, 2022
SELL
$9.96 - $23.65 $29,511 - $70,074
-2,963 Reduced 81.69%
664 $16,000
Q4 2021

Feb 14, 2022
BUY
$14.0 - $28.44 $43,302 - $87,964
3,093 Added 579.21%
3,627 $65,000
Q3 2021

Nov 15, 2021
SELL
$7.28 - $30.97 $8,146 - $34,655
-1,119 Reduced 67.7%
534 $15,000
Q2 2021

Aug 16, 2021
BUY
$8.09 - $12.0 $5,120 - $7,596
633 Added 62.06%
1,653 $17,000
Q1 2021

May 17, 2021
SELL
$10.94 - $15.32 $45,718 - $64,022
-4,179 Reduced 80.38%
1,020 $12,000
Q4 2020

Feb 16, 2021
SELL
$7.84 - $13.4 $65,511 - $111,970
-8,356 Reduced 61.65%
5,199 $61,000
Q3 2020

Nov 16, 2020
BUY
$7.22 - $20.7 $80,026 - $229,438
11,084 Added 448.56%
13,555 $107,000
Q2 2020

Aug 13, 2020
BUY
$9.11 - $22.06 $22,510 - $54,510
2,471 New
2,471 $45,000
Q4 2019

Feb 07, 2020
SELL
$4.46 - $18.14 $4,152 - $16,888
-931 Closed
0 $0
Q3 2019

Nov 05, 2019
BUY
$6.64 - $14.89 $6,181 - $13,862
931 New
931 $6,000

Others Institutions Holding FULC

# of Institutions
150
Shares Held
52.2M
Call Options Held
6.91M
Put Options Held
1.9M
View Full List

About Fulcrum Therapeutics, Inc.

FULC Quotes by TradingView
  • Ticker FULC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,038,900
  • Market Cap $237M
  • Description
  • Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystro...
More about FULC
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email